BioGaia AB (publ)

BioGaia AB (publ)

BIOGY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.26B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BioGaia AB (publ)BioGaia AB (publ)32.63.17%32%0.8-
$9.60

Current Fair Value

22.9% downside

Overvalued by 22.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.26 Billion
Enterprise Value$735.24 Million
Annual dividend$0.42
Dividend yield3.17%
Earnings per Share$3.29
Beta0.32
Outstanding Shares101,124,000

Return

Return on Equity31.55%ROE
Return on Assets26.56%
Return on Invested Capital47.38%

Valuation & Multiples

P/E Ratio32.64P/E Ratio
PEG48.52PEG
Price to Sales0.78Price to Sales
Price to Book Ratio1.04Price to Book Ratio
Enterprise Value to Revenue0.45
Enterprise Value to EBIT1.23
Enterprise Value to Net Income1
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 22, 2026
EPS Estimate
$0.90
Consensus analyst estimate
Revenue Estimate
$383.54 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About BioGaia AB (publ)

251 employees
CEO: Theresa Agnew

BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantag...

Questions & Answers